Publications:

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor.

Cancer Communications (London, England)

Karimi, Leena L; Alves, Carla L CL; Terp, Mikkel G MG; Tuttolomondo, Martina M; Portman, Neil N; Ehmsen, Sidse S; Johansen, Lene E LE; Bak, Martin M; Lim, Elgene E; Ditzel, Henrik J HJ

Publication Date: 2023-04-26

Variant appearance in text: RB1: 2125T>G; Tyr709Asp

PubMed Link: 37101393

Variant Present in the following documents:

• Main text
• CAC2-43-720.pdf

View BVdb publication page

Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients.

Frontiers In Oncology

Yuan, Ting T; Wang, Xin X; Sun, Sijin S; Cao, Zheng Z; Feng, Xiaoli X; Gao, Yibo Y

Publication Date: 2021

Variant appearance in text: RB1: 2125T>G; Tyr709Asp

PubMed Link: 34168983

Variant Present in the following documents:

• DataSheet_2.xlsx, sheet 3

View BVdb publication page